Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs

Datos Bibliográficos

ID14909587
AutoresCaroline Chatwin (0000-0002-7124-2264, University of Kent, autor de correspondencia), Fiona Measham (0000-0002-9322-1931, Durham University), Kate O’brien (0009-0008-4398-4982, Durham University), Harry Sumnall (0000-0002-7841-9245, Liverpool John Moores University)
Año2017
Volumen40
Páginas1-5
Fecha de publicación2017-02-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Drug Policy (JOURNAL)
Identificadores de la revistaISSN: 0955-3959 • E-ISSN: 1873-4758
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2017.01.016
PMID28164859
OpenAlexW2585727529
IdiomaEN
Citas recibidas9
Referencias citadas33

Business · Cannabinoid · Cannabis · Environmental health · Harm · Harm reduction · Population · Psychiatry · Psychoactive substance · Public health · Synthetic cannabinoids · Cannabis and Cannabinoid Research · HIV, Drug Use, Sexual Risk · Homelessness and Social Issues · Medicine · Nursing · Psychology · Social Psychology

  • Power, morality and policy

    Greg Los•Drugs, Habits and Social Policy•2026

  • Cognitive Enhancing Drugs in Sport

    Aaron C T Smith, Constantino Stavros et al.•Substance Use & Misuse•2020

  • Critically explaining British policy responses to novel psychoactive substances using the policy constellations framework

    Open Access•Greg Los•Drugs Education Prevention and…•2024

  • Instrumentalising therapeutic and enhancement drugs as pharmacological technologies with politicogenic drug effects

    Open Access•Aleksi Hupli•Drugs Education Prevention and…•2023

  • Streets of the ‘spice zombies’

    Open Access•Liviu Alexandrescu•Crime Media Culture An…•2019

  • Social inclusion from on high

    Open Access•Dan Allman•International Journal of Drug…•2019

  • Monitoring new psychoactive substances

    Open Access•Damien Rhumorbarbe, Marie Morelato et al.•International Journal of Drug…•2019

  • The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population

    Open Access•Robert Ralphs, Rob Ralphs et al.•International Journal of Drug…•2021

  • Beyond Treatment Versus Enhancement

    Open Access•Aleksi Hupli, Gabija Didžiokaitė et al.•Contemporary Drug Problems•2019

  • The decline of ecstasy, the rise of ‘binge’ drinking and the persistence of pleasure

    Open Access•Fiona Measham•Probation Journal•2004

  • Social suppliers

    Open Access•Katinka Van De Ven, Kyle J D Mulrooney et al.•International Journal of Drug…•2017

  • Psychedelics and cognitive liberty

    Open Access•Charlotte Walsh•International Journal of Drug…•2016

  • Legally flawed, scientifically problematic, potentially harmful

    Open Access•Alex Stevens, Rudi Fortson et al.•International Journal of Drug…•2015

  • The risk environment of anabolic–androgenic steroid users in the UK

    Open Access•Gisella Hanley Santos, Ross Coomber•International Journal of Drug…•2017

  • The hidden web and the fentanyl problem

    Open Access•P Quintana, Mireia Ventura et al.•International Journal of Drug…•2017

  • Assessing the ‘added value’ of European policy on new psychoactive substances

    Open Access•Caroline Chatwin•International Journal of Drug…•2017

  • New psychoactive substances

    Open Access•Peter Reuter, Bryce Pardo•International Journal of Drug…•2017

  • They’re legal so they’re safe, right?” What did the legal status of BZP-party pills mean to young people in New Zealand

    Open Access•Janie Sheridan, Rachael Butler•International Journal of Drug…•2010

  • NPS and the methadone queue

    Open Access•Liviu Alexandrescu•International Journal of Drug…•2017

  • Drug policy and global regulatory capitalism

    Open Access•Toby Seddon•International Journal of Drug…•2014

  • I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances

    Open Access•Allison Matthews, Rachel Sutherland et al.•International Journal of Drug…•2017

  • New psychoactive substances (NPS) on cryptomarket fora

    Open Access•Marie Claire Van Hout, Evelyn Hearne•International Journal of Drug…•2017

  • Health and Social Care workers’ perceptions of NPS use in Northern Ireland

    Open Access•Anne Campbell, Nina O Neill et al.•International Journal of Drug…•2017

  • From niche to stigma—Headshops to prison

    Open Access•Blackman, Shane Blackman et al.•International Journal of Drug…•2017

  • Have prohibition policies made the wrong decision? A critical review of studies investigating the effects of DMAA

    Open Access•Matthew Dunn•International Journal of Drug…•2017

  • New psychoactive substances

    Open Access•Alessandro Pirona, Alessandra Bo et al.•International Journal of Drug…•2017

  • Experiences with mephedrone pre- and post-legislative controls

    Open Access•Karen Mcelrath, Christina O’Neill•International Journal of Drug…•2011

  • Blurred Boundaries

    Open Access•Caroline Chatwin, Gary R Potter et al.•Contemporary Drug Problems•2014

Obras citantes distintas9
Citas por año1,29
Intervalo de citas2019 - 2026 (8)
Velocidad de citacióncurrent
Altamente citadoNo
Tipos de citaNeutras: 9
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae